Pneumococcal Disease Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- PCV13
- Bryant, Arkansas
- +16 more
2022-04-06
Apr 6, 2022P
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 - 2021
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
- Anaheim, California
- +28 more
2022-03-23
Mar 23, 2022P
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- Nedlands, Western Australia, Australia
- +65 more
2022-03-22
Mar 22, 2022P
Active, not recruiting
- Pneumococcal Disease
- 20vPnC
- +3 more
- Itoshima, Fukuoka, Japan
- +27 more
2022-03-16
Mar 16, 2022P
Completed
- Pneumococcal Disease
- Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
- Mobile, Alabama
- +62 more
2022-02-25
Feb 25, 2022P
Active, not recruiting
- Pneumococcal Disease
- 20vPnC
- Fayetteville, Arkansas
- +41 more
2022-02-25
Feb 25, 2022P
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- Birmingham, Alabama
- +108 more
2022-02-07
Feb 7, 2022P
Completed
- Pneumococcal Disease
- 20vPnC
- +3 more
- Birmingham, Alabama
- +67 more
2021-11-29
Nov 29, 2021M
Active, not recruiting
- Pneumococcal Disease
- V114
- Jeonju-si, Jeonrabugdo, Korea, Republic of
- +18 more
2021-11-17
Nov 17, 2021P
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- Tucson, Arizona
- +97 more
2021-11-10
Nov 10, 2021P
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- Nagoya-shi, Aichi, Japan
- +38 more
2021-11-10
Nov 10, 2021E
Completed
- Pneumococcal Disease
- EuPCV15
- Prevenar13
- Seoul, Korea, Republic ofThe Catholic University of Seoul St.Mary's Hospital
2021-10-06
Oct 6, 2021A
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- +2 more
- Banning, California
- +25 more
2021-09-27
Sep 27, 2021P
Completed
- Pneumococcal Disease
- 13vPnC
- +2 more
- Mobile, Alabama
- +41 more
2021-02-02
Feb 2, 2021P
Completed
- Pneumococcal Disease
- 20vPnC
- 13vPnC
- Anaheim, California
- +20 more
2020-11-03
Nov 3, 2020P
Completed
- Meningococcal Disease
- +4 more
- Menjugate
- +2 more
- London, United KingdomSt George's Vaccien Institute
2020-09-29
Sep 29, 2020P
Completed
- Pneumococcal Disease
- Kisumu, KenyaKenya Medical Research Institute/Walter Reed Project
2020-02-03
Feb 3, 2020P
Completed
- Pneumococcal Disease
- SIILPCV10
- +2 more
- Fajara, GambiaMedical Research Council (MRC) Unit, The Gambia
2019-06-11
Jun 11, 2019P
Completed
- Pneumococcal Disease
- Stevenage, Hertfordshire, United Kingdom
- +2 more
2019-03-20
Mar 20, 2019P
Completed
- Pneumococcal Disease
- Blood draw
- Longan County, Guangxi, China
- +9 more
2018-11-30
Nov 30, 2018P
Completed
- Pneumococcal Disease
- Non Intervention
- Athens, Attiki, Greece
- +20 more
2018-11-30
Nov 30, 2018M
Completed
- Pneumococcal Disease
- Pneumovax™ 23
- (no location specified)
2018-10-01
Oct 1, 2018P
Completed
- Pneumococcal Disease
- Non-intervention
- Jung-gu, Daejeon, Korea, Republic of
- +26 more
2017-03-06
Mar 6, 2017P
Completed
- Pneumococcal Disease
- Prevenar 13
- Lipa City, Batangas, Philippines
- +120 more
2016-12-05
Dec 5, 2016U
Completed
- Pneumococcal Disease
- Prevenar 13
- Pneumovax II
- Oxford, United KingdomOxford Vaccine Group
2015-11-06
Nov 6, 2015